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Membrane Trafficking of Collecting Duct Water 
Channel Protein AQP2 Regulated by Akt/AS160
Akt (protein kinase B (PKB)) is a serine/threonine kinase that acts in the 
phosphatidylinositol 3-kinase (PI3K)/Akt signaling pathway. The PI3K/
Akt signaling pathway, triggered by growth factors and hormones including 
vasopressin, is an important pathway that is widely involved in cellular 
mechanisms regulating transcription, translation, cell growth and death, cell 
proliferation, migration, and cell cycles. In particular, Akt and Akt substrate 
protein of 160 kDa (AS160) are likely to participate in the trafficking of 
aquaporin-2 (AQP2) in the kidney collecting duct. In this study, we demonstrated 
that 1) small interfering RNA (siRNA)-mediated gene silencing of Akt1 significantly 
decreased Akt1 and phospho-AS160 protein expression; and 2) confocal laser 
scanning microscopy of AQP2 in mouse cortical collecting duct cells (M-1 cells) 
revealed AS160 knockdown by siRNA increased AQP2 expression in the plasma 
membrane compared with controls, despite the absence of dDAVP stimulation. 
Thus, the results suggest that PI3K/Akt pathways could play a role in AQP2 
trafficking via the AS160 protein. 
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PI3K/Akt signaling
1. Akt phosphorylation induced by the phosphatidylino-
sitol 3-kinase (PI3K) activation
PI3K activation by certain growth factors and hormones 
induces the conversion of lipid phosphatidylinositol-4,5-
bisphosphate [PI(4,5)P2] to phosphatidylinositol-3,4,5-
triphosphate [PI(3,4,5)P3]
1). The PI(3,4,5)P3 product 
provides the direct binding sites to effector proteins 
having pleckstrin-homology (PH) domains that are 
accumulated at the region of PI3K activation. Akt (protein 
kinase B (PKB)) and phosphoinositide-dependent 
kinase 1 (PDK1) are well-known PI(3,4,5)P3-binding 
proteins and are the key mediators in the PI3K signaling 
pathway. Interaction between PI(3,4,5)P3 and the effector 
proteins stimulates phosphorylation of Akt which is 
catalyzed by autophosphorylation of PDK1
2). In turn, the 
phosphorylation of Akt catalyzes the kinase activity of Akt, 
resulting in the phosphorylation of downstream effector 
proteins. 
The kinase activity of Akt is dependent on phosphoryla-
tion at T308 and S473. While T308 phosphorylation of Akt 
is catalyzed by PDK1, the phosphorylation of S473 in the 
hydrophobic motif of the C-terminal tail is mainly regulated 
by the mammalian target of rapamycin (mTOR)
3). 
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2. Expression of Akt isoforms 
Three isoforms of the mammalian Akt have been found, 
and the Akt (PKB) gene family consists of Akt1, Akt2, and 
Akt3. Although they are encoded from different genes, 
isoforms of Akt have a similar structural homology of over 
80% that is composed of an N-terminal PH domain, a 
central kinase catalytic domain and a C-terminal extension 
containing a regulatory hydrophobic motif
4). Both pho-
sphorylation sites, threonine in a kinase catalytic domain 
and serine in regulatory motif, are conserved in T308 and 
S473 of Akt1, T309 and S474 of Akt2, and T305 and S472 
of Akt3. 
Despite their structural similarity, the three isoforms show 
different expressions and functions. Akt isoforms are widely 
expressed in normal tissues as well as in various tumor 
cells
5). Akt1 is localized in the nucleus and the cytoplasm and 
translocated to the plasma membrane (PM) by stimulation. 
Akt2 is colocalized with the mitochondria, while Akt3 is 
localized in both the nucleus and nuclear membrane
6). 
Trafficking of membrane protein by Akt signaling
1. Trafficking of membrane protein regulated by PI3K/Akt 
signaling 
Akt signaling is involved in the maintenance of metabolic 
homeostasis through regulation of the membrane protein 
trafficking as well as other intracellular protein trafficking. 
PI3K/Akt signaling is known to maintain the lipid 
homeostasis by regulating the translocation of surfactant 
protein A (SP-A) receptor p63 to the PM
7). Moreover, 
Sharpe et al.
8) reported that Akt regulates the early 
secretory pathway from ER to Golgi by phosphorylation 
of Sec24 protein involved in cargo selection. Furthermore, 
Robertson et al.
9) demonstrated that acute insulin-stimulated 
Akt signaling decreases the surface expression of the 
norepinephrine transporter in the mouse hippocampus.
One of the well-known functions of Akt is to regulate 
glucose homeostasis. In Akt1-knockout mice, deletion of 
Akt1 inhibits the translocation of GLUT1 to the PM, and 
leads to reduced glucose uptake
10). In muscle and fat cells, 
Akt and protein kinase C (PKC) are key signaling mediators 
of the PI3K pathway in the insulin-regulated transport of 
glucose into cells via glucose transporter GLUT4
11, 12). It was 
reported that AS160 (Akt substrate of 160 kDa, originally 
named TBC1D4 of the TBC family, Tre-2/Bub2/cdc16) is a 
downstream mediator of Akt signaling during the process 
of GLUT4 trafficking
13). AS160 contains a Rab GTPase-
activating protein (GAP) domain. It is proposed that Akt-
induced phosphorylation of AS160 inhibits its GAP activity, 
leading to an increase in the active GTP-bound form of 
the AS160 target Rab proteins for vesicle trafficking
14). 
Therefore, AS160, a downstream effecter protein of Akt 
signaling, could contribute to the regulation of Rab proteins 
associated with intracellular vesicle trafficking, possibly for 
aquaporin-2 (AQP2) in the kidney collecting ducts. 
2. Akt signaling-associated Rab proteins in membrane 
protein trafficking
Rab proteins have been known to be a key mediator of 
regulated vesicle trafficking. Previous studies demonstrated 
that Rab proteins are associated with Akt signaling: (1) 
Both Rab 5 and Akt signaling are required to regulate 
insulin receptor-mediated endocytosis
15, 16); (2) Rab 10 is 
involved Na
+,K
+-ATPase translocation to the PM by insulin-
stimulated Akt activation
17); (3) Rab 11-mediated Akt 
signaling promotes glucose uptake via GLUT1 trafficking
18); 
(4) Rab 4 was identified as a specific Akt2 substrate in the 
modulating of GLUT4 vesicle trafficking
19); (5) Rab 10 also 
mediated the regulatory signaling of GLUT4 trafficking 
dependent on the Akt pathway
20-22); and (6) Rab 11 
activation by Akt phosphorylation induced internalization 
and recycling of the insulin-like growth factor type-1 
receptor and GLUT4 trafficking
23-25). Electrolyte Blood Press 8:59-65, 2010 • doi: 10.5049/EBP.2010.8.2.59    61
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Akt signaling and Akt-associated Rab proteins in 
AQP2 membrane trafficking
1. Akt signaling for regulation of AQP2 protein expression
AQP2 is the water channel protein expressed in the 
renal connecting tubule and collecting duct. Cell surface 
expression of AQP2 is regulated by arginine vasopressin 
(AVP)
26, 27). Binding of vasopressin to vasopressin V2 
receptor (V2R) in the basolateral PM stimulates adenylyl 
cyclase which converts ATP to cyclic AMP (cAMP). In 
turn, cAMP activates the protein kinase A (PKA) signaling 
pathway that is the major signaling pathway for AQP2 
trafficking and up-regulation of AQP2 expression. 
Recently, the Akt signaling pathway has been proposed 
to be another significant signaling pathway for regulation   
of AQP2
28). Insulin, one of the most potent hormones for 
Akt activation, stimulates the PI3K/Akt pathway via insulin 
receptor and increased AQP2 expression in primary cultures 
of the inner medullary collecting duct (IMCD) cells of the 
rat kidney. Moreover, a recent study suggested that AVP 
stimulates PI3K/Akt signaling pathways
29), by demonstrating 
that dDAVP stimulates Akt phosphorylation in rat kidney 
IMCD tubule suspension. 
2. Akt-dependent signaling pathway for the regulation of 
AQP2 trafficking
Rab GTPases are important mediators for Akt-dependent 
intracellular vesicle trafficking. Transcripts of several Rab 
proteins were found in the IMCD of the rat kidney by 
transcriptional profiling analysis
30). Morevoer, Rab proteins 
were identified in the AQP2-expressing vesicles from 
IMCD cells of the rat kidney by LC-MS/MS analysis
31). 
Among Rab proteins identified by proteomic analysis, seven 
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Fig. 1. Regulation of aquaporin-2 (AQP2) in response to dDAVP treatment in mouse cortical collecting 
duct cells (M-1 cells). A and B) Immunofluorescence microscopy of AQP2. Short-term dDAVP-
treatment (10
-8 M) for 15 minutes in M-1 cells increased AQP2 trafficking to the plasma membrane 
(indicated by arrows in B), compared with vehicle-treated M-1 cells (A). C and D) Semiquantitative 
immunoblotting of AQP2. Immunoblots reacted with anti-AQP2 revealed 29- and 35- to 50-kDa 
AQP2 bands, representing nonglycosylated and glycosylated forms of AQP2, respectively. AQP2 
expression was significantly increased in 2 day-dDAVP-treated M-1 cells, compared with either 
vehicle-treated or 1 day-dDAVP-treated M-1 cells. n, the number of separate M-1 cell lysates.
*P < 0.05 when compared to the vehicle-treated control group. 
†P < 0.05 when compared to the 1 day-dDAVP treated group. 62      HJ Jung et al.  • The Role of Akt/AS160 in AQP2 Trafficking
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Rab proteins (Rab 4, 5, 7, 11, 18, 21 and 25), have been 
known to be involved in the trafficking of endosomes. In 
addition, Rab 5, Rab 7 and Rab 11 were detected in the 
AQP2-immunoisolated vesicles by immunogold staining 
for electron microscopy. Rab 4, Rab 5, Rab 7 and Rab 
11 were also found in the AQP2-expressing vesicles by 
immunoblotting
31). Importantly, Rab 2, Rab 10 and Rab 14 
are the AQP2 vesicle-associated Rab proteins and are also 
reported as target substrates of AS160 in insulin-stimulated 
Akt singaling
14). 
Indeed, we examined whether AS160, a novel Akt 
substrate, plays a role in the regulation of AQP2 trafficking 
in the kidney collecting duct cells. The main strategy was 
to examine whether AS160 knockdown in mouse cortical 
collecting duct cells (M-1 cells) by small interfering RNA 
(siRNA)-mediated gene silencing could affect the AQP2 
trafficking to the PM. The results were summarized below. 
Results 
1. Regulation of AQP2 expression in M-1 cells in response 
to dDAVP treatment
Immunofluorescence microscopy demonstrated that 
short-term dDAVP treatment (10
-8 M, 15 minutes) increased 
AQP2 labeling intensity in the PM of M-1 cells (arrows in 
Fig. 1B), compared with vehicle-treated M-1 cells (Fig. 1A). 
Moreover, AQP2 expression (both deglycosylated ~28 
kDa and glycosylated ~35–50 kDa bands) was significantly 
increased in response to 2 day-dDAVP (10
-8 M) treatment 
(130 ± 4% of vehicle-treated control levels, P < 0.05), 
compared with either vehicle (100 ± 7%) or 1 day-dDAVP 
(10
-8 M) treatment (107 ± 4%, Fig. 1C and 1D). This 
indicates that AQP2 is endogenously expressed in M-1 cells, 
a mouse cortical collecting duct cell line, and its expression 
is regulated by both short-term and long-term treatment of 
dDAVP. 
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Fig. 2. Semiquantitative immunoblotting of Akt1 and AQP2, aquaporin-2 (AQP2) in mouse cortical 
collecting duct cells (M-1 cells) with Akt1 knockdown. A and B) Immunoblots reacted with anti-Akt1 
revealed 60-kDa Akt1 bands. Akt1-directed small interfering RNA (siRNA) treatment decreased Akt1 
expression. C and D) Immunoblots reacted with anti-AQP2 revealed 29- and 35- to 50-kDa AQP2 
bands, representing nonglycosylated and glycosylated forms of AQP2, respectively. AQP2 expression 
was unchanged in M-1 cells with Akt1 knockdown. n, the number of separate M-1 cell lysates.
*P < 0.05 when compared to control non-targeting siRNA-transfected M-1 cells. Electrolyte Blood Press 8:59-65, 2010 • doi: 10.5049/EBP.2010.8.2.59    63
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2. Decreased Akt1 but unchanged AQP2 expression in M-1 
cells with Akt1 knockdown 
Akt1-directed siRNA significantly decreased Akt1 
protein expression (27 ± 1% of control levels, non-targeting 
siRNA-transfected M-1 cells, P < 0.05, Fig. 2A and 2B). 
Importantly, AQP2 protein expression was unchanged (116 
± 2%, not significant) in response to Akt1 knockdown (Fig. 
2C and 2D). In addition, M-1 cells with Akt1 knockdown 
for 48 hours demonstrated no changes in morphology and 
cell number compared with control M-1 cells transfected 
with non-targeting siRNA (not shown). 
3. Decreased phospho-AS160 expression in M-1 cells 
with Akt1 knockdown
One more set of Akt1 knockdown [Akt1 expression: 12 
± 2% of control levels (non-targeting siRNA-transfected 
M-1 cells), P < 0.05, data not shown)] was made. Akt1 
knockdown was associated with unchanged or marginally 
increased total AS160 expression (vehicle-treated group: 
128 ± 7%, P = 0.054 and short-term dDAVP-treated 
group, 10
-8 M, 10 minutes, 138 ± 9%, P < 0.05, Fig. 3A 
and 3B). Importantly, the expression of phospho-AS160 
was unchanged indicated by an arrow in Fig. 3A, and 
hence, the phospho-AS160 values normalized to the total 
AS160 protein values were markedly decreased (Fig. 3C). 
For phosphoproteins, the phosphoprotein values were 
normalized to the total protein values (i.e., log2 [(Fep/Fcp)/
(Fet/Fct)], where F = band intensity, e = experiment, c 
= control, p = phosphoprotein, and t = total protein, as 
previously demonstrated)
29). The number of replicates (n) 
in the figures indicates the number of separate cell lysates 
examined. This indicates that AS160 expression and 
phosphorylation of AS160 are dependent on Akt.  
4. Increased AQP2 immunolabeling density of the PM in 
M-1 cells with AS160 knockdown despite the absence 
of dDAVP stimulation
As shown in Fig. 4, AQP2-labeled M-1 cells were 
randomly selected in each group (asterisk in Fig. 4A). The 
total pixel intensity of the PM (Fig. 4C) and the whole 
cell (both PM and cytosol except nucleus, Fig. 4D) were 
acquired, respectively. The ratio of total pixel intensity in 
the PM to that of the whole cell (ratio of PM/Total, Fig. 4G) 
from the randomly selected cells in each group was acquired. 
The ratio is a measure of surface AQP2 normalized for the 
whole cell AQP2 expression, and the changes of this ratio 
would demonstrate the changes of the surface-to-total 
AQP2 distribution. Laser scanning confocal microscopic 
examination of AQP2 and quantitative analysis of AQP2 
immunolabeling density (i.e., changes of the surface-to-total 
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Fig. 3. Semiquantitative immunoblotting of Akt1, AS160, and p-AS160 
in mouse cortical collecting duct cells (M-1 cells) with Akt1 knockdown. 
A-C) Akt1 knockdown was associated with unchanged or marginally 
increased total AS160 expression. In contrast, phospho-AS160 level 
normalized to the total AS160 protein values were markedly decreased 
(~160 kDa band on PAS immunoblots indicated by an arrow in panel A). 
siRNA, small interfering RNA; n, the number of separate M-1 cell lysates.
*P < 0.05 when compared with the vehicle-treated control group (non-
targeting siRNA-transfected M-1 cells). 
†P < 0.05 when compared with dDAVP-treated control group (non-
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AQP2 distribution in the M-1 cells) demonstrated that AQP2 
expression in the PM in the vehicle-treated basal condition 
was significantly higher in the M-1 cells with AS160 
knockdown (123 ± 2%, P < 0.05, number of examined 
cells = 52, Fig. 4F and 4G) compared with the control M-1 
cells transfected with non-targeting siRNA (number of 
examined cells = 53, Fig. 4E and 4G). This indicates that 
AS160 plays a role as a negative regulator for exocytosis of 
AQP2. 
Summary
Taken together, (1) siRNA-mediated gene silencing of 
Akt1 significantly decreased Akt1 and phospho-AS160 
protein expression; and (2) confocal laser scanning 
microscopy of AQP2 in M-1 cells revealed that AS160 
knockdown by siRNA increased AQP2 expression in 
the PM compared with control, despite the absence of 
dDAVP stimulation. This finding is compatible with a 
previous study showing increased GLUT4 trafficking in 
adipocytes with AS160 knockdown despite the absence 
of insulin stimulation. Thus, the results suggest that PI3K/
Akt pathways could play a role in AQP2 trafficking via the 
AS160. 
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